Literature DB >> 7018862

Endocrine effects of acute and chronic cimetidine administration.

H E Carlson, A F Ippoliti, R S Swerdloff.   

Abstract

In normal men, acute oral administration of 300 mg cimetidine or intravenous injection of 50 mg of the drug had no effect on prolactin release. In contrast, intravenous injection of 150 or 300 mg led to substantial increments in serum prolactin. Peptic ulcer patients were randomly assigned to treatment with either cimetidine or antacid. Serial blood sampling until ulcer healing showed no significant changes in serum prolactin, testosterone, free testosterone, estradiol, LH, or FSH in either group. It is likely that the impotence and breast changes occasionally seen during cimetidine therapy are due to peripheral antagonism of androgen action rather than to alterations in circulating hormone levels.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7018862     DOI: 10.1007/bf01313585

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  26 in total

1.  Male sexual dysfunction during treatment with cimetidine.

Authors:  N R Peden; J M Cargill; M C Browning; J H Saunders; K G Wormsley
Journal:  Br Med J       Date:  1979-03-10

2.  The apparent free testosterone concentration, an index of androgenicity.

Authors:  A Vermeulen; T Stoïca; L Verdonck
Journal:  J Clin Endocrinol Metab       Date:  1971-11       Impact factor: 5.958

3.  Gynaecomastia with cimetidine.

Authors:  G F Delle Fave; G Tamburrano; L De Magistris; C Natoli; M L Santoro; R Carratu; A Torsoli
Journal:  Lancet       Date:  1977-06-18       Impact factor: 79.321

4.  Stimulation of prolactin release by intravenous cimetidine: a dose-response study.

Authors:  R Caldara; L Bierti; C Barbieri; M Cambielli; M Romussi; C Ferrari
Journal:  J Endocrinol Invest       Date:  1979 Jan-Mar       Impact factor: 4.256

5.  Radioimmunoassay for luteinizing hormone in human plasma or serum: physiological studies.

Authors:  W D Odell; G T Ross; P L Rayford
Journal:  J Clin Invest       Date:  1967-02       Impact factor: 14.808

6.  Radioimmunoassay for human follicle-stimulating hormone: physiological studies.

Authors:  W D Odell; A F Parlow; C M Cargille; G T Ross
Journal:  J Clin Invest       Date:  1968-12       Impact factor: 14.808

7.  Prolactin responses to cimetidine.

Authors:  W L Burland; R I Gleadle; R M Lee; D Rowley-Jones; G V Groom
Journal:  Br J Clin Pharmacol       Date:  1979-01       Impact factor: 4.335

8.  Cimetidine effects on prolactin release and production.

Authors:  S G Barber; A M Hoare
Journal:  Horm Metab Res       Date:  1979-03       Impact factor: 2.936

9.  Cimetidine is an antiandrogen in the rat.

Authors:  S J Winters; J L Banks; D L Loriaux
Journal:  Gastroenterology       Date:  1979-03       Impact factor: 22.682

10.  Cimetidine, a histamine H2 receptor antagonist, occupies androgen receptors.

Authors:  J W Funder; J E Mercer
Journal:  J Clin Endocrinol Metab       Date:  1979-02       Impact factor: 5.958

View more
  6 in total

Review 1.  Safety of acid-suppressing drugs.

Authors:  R A Smallwood; R G Berlin; N Castagnoli; H P Festen; C J Hawkey; S K Lam; M J Langman; P Lundborg; A Parkinson
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

2.  Effect of cimetidine on gonadal function in man.

Authors:  N R Peden; K G Wormsley
Journal:  Br J Clin Pharmacol       Date:  1982-10       Impact factor: 4.335

3.  Fertility and the aging male.

Authors:  Isiah D Harris; Carolyn Fronczak; Lauren Roth; Randall B Meacham
Journal:  Rev Urol       Date:  2011

Review 4.  Drugs and prolactin.

Authors:  Mark E Molitch
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

5.  Lack of effect of the dopamine D1 antagonist, NNC 01-0687, on unstimulated and stimulated release of anterior pituitary hormones in males.

Authors:  E Grodum; M Andersen; J Hangaard; O Koldkjaer; C Hagen
Journal:  J Endocrinol Invest       Date:  1998-05       Impact factor: 4.256

Review 6.  Adverse reactions and interactions with H2-receptor antagonists.

Authors:  J Penston; K G Wormsley
Journal:  Med Toxicol       Date:  1986 May-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.